Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Argus Health
Federal Trade Commission
Teva
Harvard Business School
Farmers Insurance
Colorcon
Healthtrust
Cipla
AstraZeneca

Generated: October 23, 2017

DrugPatentWatch Database Preview

DIASTAT ACUDIAL Drug Profile

« Back to Dashboard

Which patents cover Diastat Acudial, and what generic Diastat Acudial alternatives are available?

Diastat Acudial is a drug marketed by Valeant Pharms North and is included in one NDA.

The generic ingredient in DIASTAT ACUDIAL is diazepam. There are eight drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the diazepam profile page.

Summary for Tradename: DIASTAT ACUDIAL

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Bulk Api Vendors: see list47
Clinical Trials: see list3
Patent Applications: see list6,993
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DIASTAT ACUDIAL at DailyMed

Pharmacology for Tradename: DIASTAT ACUDIAL

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharms North
DIASTAT ACUDIAL
diazepam
GEL;RECTAL020648-007Sep 15, 2005RXYesNo► Subscribe► Subscribe► Subscribe
Valeant Pharms North
DIASTAT ACUDIAL
diazepam
GEL;RECTAL020648-006Sep 15, 2005RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: DIASTAT ACUDIAL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms North
DIASTAT ACUDIAL
diazepam
GEL;RECTAL020648-007Sep 15, 2005► Subscribe► Subscribe
Valeant Pharms North
DIASTAT ACUDIAL
diazepam
GEL;RECTAL020648-006Sep 15, 2005► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for DIASTAT ACUDIAL

Drugname Dosage Strength RLD Submissiondate
diazepamRectal Gel5 mg/mL, 2mL pre-filled syringeDiastat Acudial12/23/2008
diazepamRectal Gel5 mg/mL, 4mL pre-filled syringeDiastat Acudial12/8/2008
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Chinese Patent Office
AstraZeneca
Medtronic
McKinsey
Daiichi Sankyo
Julphar
US Department of Justice
Queensland Health
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot